Evaluation of Oxiris Membrane as a Treatment for Ischemia-reperfusion Syndrome in Cardiogenic Shock Treated With Extracorporeal Life Support (ECMO/ECLS): A Randomized Pilot Study ECMORIX

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 18, 2021

Primary Completion Date

March 10, 2023

Study Completion Date

March 10, 2023

Conditions

Cardiogenic Shock

Interventions

DEVICE

Oxiris membrane

Hemofiltration treatment with Oxiris membrane connected to the ECLS circuit for 24 hours.

DEVICE

Prismaflex membrane

Treatment by hemofiltration with PrismaFlex ST150 membrane connected to the ECLS circuit for 24 hours.

BIOLOGICAL

Blood tests

Blood tests before and just after membrane placement and at H6, H24, H48 and H72 after membrane placement

Trial Locations (1)

Chu Dijon Bourgogne, Dijon

All Listed Sponsors

lead

Centre Hospitalier Universitaire Dijon

OTHER